Home524663 • BOM
add
Bharat Immunologicals&Biologcls Corp Ltd
Nakaraang pagsara
₹23.33
Sakop ng araw
₹22.50 - ₹23.44
Sakop ng taon
₹19.00 - ₹35.88
Market cap
993.14M INR
Average na Volume
61.06K
P/E ratio
-
Dividend yield
-
Primary exchange
BOM
Mga balita tungkol sa merkado
Bloomberg.com
53 minuto ang nakalipas
US Futures Extend Wall Street Gain on Tech Results: Markets Wrap
0.98%
0.31%
0.15%
0.35%
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Set 2023info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 47.23M | — |
Net na kita | -49.18M | — |
Net profit margin | — | — |
Kita sa bawat share | — | — |
EBITDA | -46.86M | — |
Aktuwal na % ng binabayarang buwis | 26.00% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Set 2023info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 89.09M | — |
Kabuuang asset | 1.88B | — |
Kabuuang sagutin | 1.09B | — |
Kabuuang equity | 787.09M | — |
Natitirang share | 43.14M | — |
Presyo para makapag-book | 1.28 | — |
Return on assets | — | — |
Return on capital | -7.59% | — |
Cash Flow
Net change in cash
| (INR) | Set 2023info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -49.18M | — |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Bharat Immunologicals and Biologicals Corporation Limited is a Public Sector Undertaking of the Government of India. Established in 1989 in Bulandshahar, Uttar Pradesh, BIBCOL manufactures oral polio vaccines and other immunisers. The company formulates over 12.5 crore doses of OPV and had aggregated revenues of ₹30.5 crore in fiscal 2006.
BIBCOL is under the administrative control of the Department of Biotechnology, Ministry of Science and Technology. Wikipedia
Itinatag
1989
Website
